The influence of nursing-education on the side effects of patients with oral cancer therapy
Not Applicable
Recruiting
- Conditions
- malignant haematological and neoplastic diseases
- Registration Number
- DRKS00005695
- Lead Sponsor
- Hämatologisch-onkologische Praxis Altona
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
The inclusion criteria comprise a life expectancy of more than 5 months, the capability to care for themselves, read, understand and write in German language. Aside from the oral antineoplastic treatment no other cytoreductive agents are allowed.
Exclusion Criteria
Erxcluded are patients who are under psychiatric treatment.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint will be the extent and frequency of side effects from the oral antitumor therapy according to the CTC – criteria, evaluated every four weeks.
- Secondary Outcome Measures
Name Time Method The secondary endpoint will be the specific treatment adherence, the self-efficacy for coping with cancer, the subjective perception of side effects, the disease–related quality of life, satisfaction with information, and degree of coping.<br>The analysis will be based on the EORTC –C30, EORTC Info 25 and CBI-B-D scales, evaluated every eight weeks.<br>